Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2

NCT03141619 is registered in ClinicalTrials.gov with Dr. Gordon Boyd as lead sponsor.

NCT NCT03141619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03141619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2
Lead sponsor
Dr. Gordon Boyd
Phase
Observational
Overall status
Unknown status
Start date
October 13, 2017
Completion date
June 30, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, delirium, respiratory failure, shock